CMX (comics)
CMX was an imprint of DC Comics that focused on publishing manga for the North American market. Established in 2004, CMX aimed to bring a diverse range of Japanese manga titles to English-speaking audiences. The imprint was operational until 2010, when it was discontinued by its parent company.
History[edit | edit source]
CMX was launched by DC Comics in October 2004 as part of an effort to enter the growing manga market in North America. At the time, manga was becoming increasingly popular among readers, and many publishers were seeking to capitalize on this trend. CMX's initial lineup included a variety of genres, from action and adventure to romance and fantasy, catering to a wide audience.
One of the first titles published by CMX was From Eroica with Love, a classic manga series by Yasuko Aoike. The imprint also published Tenjho Tenge by Oh! great, which became one of its most well-known series. However, CMX faced criticism for its decision to edit some of the content in Tenjho Tenge to make it suitable for younger audiences, which led to controversy among fans who preferred unaltered versions of manga.
Notable Titles[edit | edit source]
CMX published a variety of manga series, some of which gained significant popularity. Notable titles include:
- Emma by Kaoru Mori - A historical romance set in Victorian England, praised for its detailed artwork and storytelling.
- Crayon Shin-chan by Yoshito Usui - A comedic series about the adventures of a mischievous young boy.
- Astral Project by Marginal and Syuji Takeya - A supernatural thriller involving astral projection and mystery.
Controversies[edit | edit source]
CMX's decision to edit certain manga titles, particularly Tenjho Tenge, sparked debates about censorship and the authenticity of translated manga. Fans argued that editing content altered the original intent of the creators and deprived readers of the full experience. Despite these controversies, CMX continued to publish a wide range of titles until its closure.
Closure[edit | edit source]
In May 2010, DC Comics announced the closure of the CMX imprint. The decision was part of a broader restructuring within the company, and it marked the end of CMX's six-year run in the manga publishing industry. The closure left several ongoing series unfinished in English translation, disappointing fans who had followed CMX's publications.
Legacy[edit | edit source]
Although CMX was short-lived, it played a role in the expansion of manga in the North American market. It introduced readers to a variety of genres and styles, contributing to the growing appreciation of manga outside Japan. The imprint's legacy is remembered by fans who enjoyed its diverse catalog and by those who continue to discuss the impact of its editorial decisions.
Also see[edit | edit source]
Page Template:Anime and manga/styles.css has no content.
Part of a series on |
Anime and manga |
---|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD